In 2013, the FDA required Daiichi Sankyo, the manufacturer of Benicar , to update its label to reflect the risk of users developing sprue-like enteropathy. This gastrointestinal disorder, caused by the death of the villi in the small intestine, mimics Celiac disease and leads to symptoms which include severe, chronic diarrhea leading to substantial weight loss, hospitalizations or even death.
Daiichi Sankyo spent nearly one billion dollars promoting Benicar®, asserting that it was superior to other drugs in its class. However, according to several studies, none of the other angiotensin receptor blocker (ARB) drugs cause the severe injuries associated with Benicar®.
If you or a loved one ingested Benicar®, Benicar HCT®, Tribenzor® or Azor® and developed chronic diarrhea or chronic vomiting that required medical care while ingesting the medicine, you may have a valuable legal claim. Give us a call today.